NCITA is a network of medical imaging experts and scientists across nine leading cancer imaging institutions across the UK, and we are building a unified infrastructure for discovery, validation and adoption of cancer imaging biomarkers into clinical trials and the NHS.

On the 27th April 2021, NCITA held a workshop on ‘Nuclear Medicine in Oncology’. The workshop provided a detailed overview of nuclear medicine in oncology, and a mix of researchers, students and managers joined the workshop to learn more about this area.

In the third of five talks, Dr Maite Jauregui-Osoro, NCITA Imaging QA/QC Manager (Imperial College London) speaks about the ‘Peculiarities of Radiopharmaceuticals’. Maite covers radiopharmaceutical concentrations, the Investigational Medicinal Product Dossier (IMPD) requirements for clinical trial authorisation using IMPs as well as how products are tested for identity and purity, and the manufacture and release of non-IMP radiotracers.

For more of our webinars and workshops please visit: [ Ссылка ]

свернуть